Stanford Scholars Respond to FDA on Regulating Gen-AI Medical Devices

Stanford scholars responded to the FDA's request for feedback on regulating generative AI-enabled medical devices, offering seven targeted recommendations to improve the FDA's two-axis risk assessment framework and balance patient safety with innovation.

This Wire brief sits within Fusion42's coverage of Medtech.